{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T19:25:46Z","timestamp":1780514746591,"version":"3.54.1"},"reference-count":19,"publisher":"Croatian Society for Medical Biochemistry and Laboratory Medicine","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochem. med. (Online)"],"published-print":{"date-parts":[[2020,6,15]]},"abstract":"<jats:p>Plasma free metanephrines or urinary fractionated metanephrines are the biochemical tests of choice for the diagnosis of pheochromocytoma as they have greater sensitivity and specificity than catecholamines for pheochromocytoma detection. This case highlights the preanalytical factors which can influence metanephrine measurement and cause a false positive result. It describes a patient with a high pre-test probability of pheochromocytoma due to hypertension and a past medical history of adrenalectomy for a purported pheochromocytoma in her home country. When biochemical screening revealed grossly elevated urine normetanephrine in the presence of a previously identified right adrenal lesion, there was high clinical suspicion of a pheochromocytoma. However, functional imaging did not support this view which prompted additional testing with plasma metanephrines. Results for plasma and urine metanephrines were discordant and preanalytical drug interference was suspected. Patient medications were reviewed and sulfasalazine, an anti-inflammatory drug was identified as the most likely analytical interferent. Urinary fractionated metanephrines were re-analysed using liquid chromatography tandem mass spectrometry (LC-MS\/MS) and all metanephrines were within their reference intervals. This case illustrates how method-specific analytical drug interference prompted unnecessary expensive imaging, heightened patient anxiety and resulted in lengthy investigations for what turned out to be a phantom pheochromocytoma.<\/jats:p>","DOI":"10.11613\/bm.2020.021003","type":"journal-article","created":{"date-parts":[[2020,6,10]],"date-time":"2020-06-10T14:12:43Z","timestamp":1591798363000},"page":"325-330","source":"Crossref","is-referenced-by-count":8,"title":["Case report of a phantom pheochromocytoma"],"prefix":"10.11613","volume":"30","author":[{"given":"Caroline M","family":"Joyce","sequence":"first","affiliation":[{"name":"Department of Clinical Biochemistry, Cork University Hospital, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Melvin","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Cork University Hospital, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula M","family":"O\u2019Shea","sequence":"additional","affiliation":[{"name":"Department of Clinical Biochemistry, Saolta University Health Care Group, Galway University Hospital, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Se\u00e1n J","family":"Costelloe","sequence":"additional","affiliation":[{"name":"Department of Clinical Biochemistry, Cork University Hospital, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domhnall J","family":"O\u2019Halloran","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Cork University Hospital, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4885","published-online":{"date-parts":[[2020,6,14]]},"reference":[{"key":"key20200610100936_r1","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0140-6736(05)67139-5","article-title":"Mannelli, Pacak K. Phaeochromocytoma.","volume":"366","author":"Lenders","year":"2005","journal-title":"Lancet"},{"key":"key20200610100936_r2","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1136\/jcp.2009.071647","article-title":"Phaeochromocytoma: diagnostic challenges for biochemical screening and diagnosis.","volume":"63","author":"Barron","year":"2010","journal-title":"J Clin Pathol"},{"issue":"6","key":"key20200610100936_r3","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1210\/jc.2014-1498","article-title":"Pheochromocytoma and Paraganglioma: An Endocrine Society Clinical Practice Guidelinea.","volume":"99","author":"Lenders","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"key20200610100936_r4","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1001\/jama.287.11.1427","article-title":"Biochemical diagnosis of phaeochromocytoma: which test is best?","volume":"287","author":"Lenders","year":"2002","journal-title":"JAMA"},{"key":"key20200610100936_r5","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.cca.2010.01.012","article-title":"Performance of plasma free metanephrine measured by liquid chromatography-tandem mass spectrometry in the diagnosis of phaeochromocytoma.","volume":"411","author":"Peaston","year":"2010","journal-title":"Clin Chim Acta"},{"key":"key20200610100936_r6","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-16-0033","article-title":"European Society of Endocrinology Clinical Practice Guideline for Long-Term Follow-Up of Patients Operated on for a Phaeochromocytoma or a Paraganglioma.","volume":"174","author":"Plouin","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"key20200610100936_r7","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1373\/clinchem.2006.075218","article-title":"Stability of Urinary Fractionated Metanephrines and Catecholamine during Collection, Shipment, and Storage of Samples.","volume":"53","author":"Willemsen","year":"2007","journal-title":"Clin Chem"},{"key":"key20200610100936_r8","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1001\/jama.2010.1563","article-title":"Biochemical misdiagnosis of phaeochromocytoma in patients treated with Sulfasalazine.","volume":"304","author":"Bouhanick","year":"2010","journal-title":"JAMA"},{"key":"key20200610100936_r9","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1210\/jc.2002-030005","article-title":"Biochemical Diagnosis of Pheochromocytoma: How to Distinguish True- from False-Positive Test Results.","volume":"88","author":"Eisenhofer","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"key20200610100936_r10","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1177\/0004563216646395","article-title":"Screening for phaeochromocytoma and paraganglioma: impact of using supine reference intervals for plasma metanephrines with samples collected from fasted\/seated patients.","volume":"54","author":"Casey","year":"2017","journal-title":"Ann Clin Biochem"},{"key":"key20200610100936_r11","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1373\/clinchem.2006.076489","article-title":"Is supine rest necessary before blood sampling for plasma metanephrines?","volume":"53","author":"Lenders","year":"2007","journal-title":"Clin Chem"},{"key":"key20200610100936_r12","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s12020-017-1300-y","article-title":"Accuracy of Recommended Sampling and Assay Methods for the Determination of Plasma-Free and Urinary Fractionated Metanephrines in the Diagnosis of Pheochromocytoma and Paraganglioma: A Systematic Review.","volume":"56","author":"D\u00e4rr","year":"2017","journal-title":"Endocrine"},{"key":"key20200610100936_r13","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1111\/ijcp.12612","article-title":"A review of the management of positive biochemical screening for phaeochromocytoma and paraganglioma: a salutary tale.","volume":"69","author":"Garrahy","year":"2015","journal-title":"Int J Clin Pract"},{"key":"key20200610100936_r14","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1055\/s-0029-1237699","article-title":"False positive test results for phaeochromocytoma from 2000 to 2008.","volume":"118","author":"Yu","year":"2010","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"key20200610100936_r15","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1177\/0004563218755817","article-title":"Falsely elevated metanephrine in patients taking midodrine.","volume":"55","author":"Emms","year":"2018","journal-title":"Ann Clin Biochem"},{"key":"key20200610100936_r16","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1373\/clinchem.2004.032912","article-title":"Pitfall in HPLC assay for urinary metanephrines: an unusual type of interference caused by methenamine intake.","volume":"50","author":"van Laarhoven","year":"2004","journal-title":"Clin Chem"},{"key":"key20200610100936_r17","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.328.7440.629","article-title":"Taverna and Krause M. Pitfalls in the diagnosis of phaeochromocytoma.","volume":"328","author":"Zendron","year":"2004","journal-title":"BMJ"},{"key":"key20200610100936_r18","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1056\/NEJMc1101502","article-title":"Drugs and Pheochromocytoma \u2013 Don\u2019t Be Fooled by Every Elevated Metanephrine.","volume":"364","author":"Neary","year":"2011","journal-title":"N Engl J Med"},{"key":"key20200610100936_r19","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1210\/jc.2012-3669","article-title":"Is the excess cardiovascular morbidity in pheochromocytoma related to blood pressure or to catecholamines?","volume":"98","author":"Stolk","year":"2013","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Biochemia medica"],"original-title":[],"link":[{"URL":"https:\/\/www.biochemia-medica.com\/en\/journal\/30\/2\/10.11613\/BM.2020.021003\/fullArticle","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,15]],"date-time":"2020-06-15T07:30:23Z","timestamp":1592206223000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.biochemia-medica.com\/en\/journal\/30\/2\/10.11613\/BM.2020.021003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,14]]},"references-count":19,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020,6,14]]},"published-print":{"date-parts":[[2020,6,15]]}},"URL":"https:\/\/doi.org\/10.11613\/bm.2020.021003","relation":{},"ISSN":["1846-7482","1330-0962"],"issn-type":[{"value":"1846-7482","type":"electronic"},{"value":"1330-0962","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6,14]]}}}